Bausch Health
BHC
#3916
Rank
C$4.64 B
Marketcap
C$12.43
Share price
28.76%
Change (1 day)
51.15%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): C-$4.07

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is C-$4.12. In 2025 the company made an earnings per share (EPS) of C$0.59 an increase over its 2024 EPS that were of C-$0.17.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.07-795.02%
2025C$0.59-450%
2024C-$0.17-92.59%
2023C-$2.26160.89%
2022C-$0.87-76.64%
2021C-$3.7168.45%
2020C-$2.20-68.91%
2019C-$7.08-57.11%
2018C-$16.51-272.22%
2017C$9.59-199.29%
2016C-$9.66798.7%
2015C-$1.07-128.31%
2014C$3.80-204.62%
2013C-$3.63602.7%
2012C-$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.13-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.33-67.80%๐Ÿ‡บ๐Ÿ‡ธ USA